What comes next? The SPIKES protocol and the subject of prognosis

Nicolas Schönfeld (Berlin, Germany)

Source: International Congress 2015 – Deliver bad news
Session: Deliver bad news
Session type: How to
Number: 203

Slide presentation

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
Nicolas Schönfeld (Berlin, Germany). What comes next? The SPIKES protocol and the subject of prognosis. International Congress 2015 – Deliver bad news

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
More than just a study subject?
Source: Annual Congress 2013 –ELF/ERS “Effective engagement of patients and the public in science, healthcare and the media”
Year: 2013

What do we need from our patients? - the clinician's point of view
Source: International Congress 2014 – PG17 Lung cancer: the issue with the tissue
Year: 2014




Workable instruments and tools realising active patient participation: a set of criteria from the patient's perspective
Source: Annual Congress 2011 - The value of patients as partners in research
Year: 2011


What tissues do we obtain from our patients? - the pathologist's point of view
Source: International Congress 2014 – PG17 Lung cancer: the issue with the tissue
Year: 2014

Key patients' needs: a patient's perspective
Source: Eur Respir Monogr 2016; 71: 243-252
Year: 2016


Debate "the best way to measure sensory function in man"
Source: Research Sem. 13
Year: 2013


Making clinical sense of the explosion in biologics - which drug for which patient and why?
Source: International Congress 2019 – PG10 Severe asthma in adults: systematic assessment and biological treatment
Year: 2019


A time to live, a time to die, but who decides when, and why? Advance decision making for two patients with ALS
Source: Annual Congress 2009 - Difficult ethical decisions Grand Round - An interactive session
Year: 2009


Pushing the limits, real benefit for the patient ? – a curative treatment approach in an unfit lung cancer patient
Source: International Congress 2017 – GR2 Lung Cancer Grand Round
Year: 2017


COPD and Me: The development and implementation of an individual patient management plan and patient hand held record
Source: Annual Congress 2010 - Optimising the care and management of patients with COPD
Year: 2010



Introducing a new formulation of pirfenidone to reduce tablet burden for the IPF patient: Is it tolerable? Is it easy to take? What do our patients think?
Source: International Congress 2018 – Management of idiopathic interstitial pneumonias: established and new treatments
Year: 2018


How should tumour sample analysis be applied to patient management?
Source: International Congress 2014 – PG17 Lung cancer: the issue with the tissue
Year: 2014




How do we know what works? Clinical trial end-points and quality of life assessment
Source: Eur Respir Monogr 2018; 81: 99-132
Year: 2018


Let's start with the end-user, patients and digital: will they work together?
Source: Virtual Congress 2020 – Digital health: a brave new world?
Year: 2020

Do we have enough evidence overall, or should we wait for ongoing trials?
Source: International Congress 2014 – From respiratory infections to wheezing: reevaluating the role of vitamin D levels in childhood
Year: 2014



Do the current endpoints in IPF clinical trials allow good regulatory decisions to be made?
Source: International Congress 2014 – Ceremony for the ERS Rare Pulmonary Disease Research Award 2014 followed by the symposium "Challenges in endpoints for rare lung diseases"
Year: 2014